Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 21Head and Neck Neoplasms 17Prostatic Neoplasms 15Neoplasms 12Lung Neoplasms 12Radiation Injuries 9Esophageal Neoplasms 8Rectal Neoplasms 7Glioma 7Brain Neoplasms 7Glioblastoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Hepatocellular 4Stomach Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Astrocytoma 3Xerostomia 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Pelvic Neoplasms 2Osteoradionecrosis 2Lymphedema 2Kidney Neoplasms 2Esthesioneuroblastoma, Olfactory 2

Interventions

Drug Therapy 2Tyrosine Kinase Inhibitors 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Semen Analysis 1Registries 1Radiotherapy 1Patient Reported Outcome Measures 1Lenalidomide 1Interviews as Topic 1Data Collection 1Cisplatin 1Choledochostomy 1Bleomycin 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms, Second Primary × Radiotherapy × Clear all
NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

Peking University First Hospital

Completed
72,408 enrolled
Genitourinary

Kidney Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡